David Hardwicke

Co-Founder at Aerska

Speaker

David Hardwicke is a co-founder and leads Business Development at Aerska, a company advancing next generation RNAi therapeutics for neurological diseases. His background spans biotech entrepreneurship, venture investing, and strategy across cell and gene therapy and RNA therapeutics, with prior roles at AveXis (Novartis Gene Therapies), ONK Therapeutics, and Pathway Bioventures. He holds degrees from the University of Notre Dame, US and University College Cork, Ireland.